08.2025

Congratulations to our portfolio company, Orbit Genomics®, for taking first grand prize in the 2025 Startup Prize: Focus on Health competition. Orbit Genomics is advancing precision medicine with its patented, AI-powered OrbiSeq™ platform, beginning with diagnosis of early-stage lung cancer. Orbit Genomics is the winner of the non-FDA track competition from a group of 75 early-stage health companies from 23 states around the US. See www.orbitgenomics.com for more information.